Unknown

Dataset Information

0

Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium.


ABSTRACT: Widespread antibiotic resistance has been reported in enterococcal pathogens that cause life-threatening infections. Enterococci species rapidly acquire resistance and the pace of new antibiotic development is slow. Drug repurposing is a promising approach in solving this problem. Bithionol (BT) is a clinically approved anthelminthic drug. In this study, we found that BT showed significant antimicrobial and antibiofilm effects against Enterococcus faecalis and vancomycin-resistant Entercococcus faecium in vitro, in a dose-dependent manner, by disrupting the integrity of the bacterial cell membranes. Moreover, BT effectively reduced the bacterial load in mouse organs when combined with conventional antibiotics in a peritonitis infection model. Thus, BT has shown potential as a therapeutic agent against E. faecalis- and vancomycin-resistant E. faecium-related infections.

SUBMITTER: She P 

PROVIDER: S-EPMC8138570 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6893902 | biostudies-literature
| S-EPMC8254471 | biostudies-literature
2020-11-25 | GSE115009 | GEO
| S-EPMC521886 | biostudies-literature
| S-EPMC7400228 | biostudies-literature
| S-EPMC6532320 | biostudies-literature
| S-EPMC3632760 | biostudies-other
| S-EPMC5506224 | biostudies-literature
2014-07-08 | GSE59190 | GEO
2022-11-28 | PXD031577 | Pride